Current and Future Perspectives for Drug Delivery and Formulation

• Delivery to Special Patient Populations: Geriatrics and Paediatrics
• Next-Generation Cell and Gene Therapies
• Optimizing Cancer Care in the Out-Patient Setting
• Personalized Medicine and the Role of Digital Health
• Non-invasive Delivery of Biologics (Pulmonary & Nasal)
• Lipid Nanoparticles for drug and vaccine delivery
• Expanding Opportunities for Nanomedicine
• Progress of Oral Biologics Delivery

Donna French, Vice President Pharma Development  , AstraZeneca